Quick answer
Knight-Swift Transportation Holdings Inc. (KNX) reported revenue of $7.47B and net income of $65.9M for the fiscal year ended 2025-12-31, up 0.8% from $7.41B the year before, per its 10-K filed with the SEC on 2026-02-19. Long-term debt stood at $1.74B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $7.47B | $65.9M | $1.74B |
| 2024 (FY ending 2024-12-31) | $7.41B | $117.6M | $1.83B |
| 2023 (FY ending 2023-12-31) | $7.14B | $217.1M | $1.63B |
| 2022 (FY ending 2022-12-31) | $7.43B | $771.3M | $1.08B |
| 2021 (FY ending 2021-12-31) | $6.00B | $743.4M | $1.51B |
| 2020 (FY ending 2020-12-31) | $4.67B | $410.0M | $508.9M |
| 2019 (FY ending 2019-12-31) | $4.84B | $309.2M | $643.8M |
| 2018 (FY ending 2018-12-31) | $5.34B | $419.3M | $365.0M |
| 2017 (FY ending 2017-12-31) | $2.43B | $484.3M | $364.8M |
| 2016 (FY ending 2016-12-31) | $1.12B | $93.9M | $0.0M |
Related
- KMI revenue, net income and debt history (Kinder Morgan, Inc.)
- KNSL revenue, net income and debt history (Kinsale Capital Group, Inc.)
- KNTK revenue, net income and debt history (Kinetik Holdings Inc.)
- KO revenue, net income and debt history (Coca Cola Co)
- KR revenue, net income and debt history (Kroger Co)
- KRYS revenue, net income and debt history (Krystal Biotech, Inc.)
- KVUE revenue, net income and debt history (Kenvue Inc.)
- KYMR revenue, net income and debt history (Kymera Therapeutics, Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.